JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 29 October 2001. doi:10.1083/jcb1553iti4
This Article
Right arrow Full Text (PDF, 211K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2001/10/323-a $5.00
The Journal of Cell Biology, Volume 155, Number 3, October 29, 2001 323-a-323


In This Issue

Death by unligated integrin


Unligated integrin tails (red) colocalize with caspases (green).

Integrins have traditionally beenconsidered relatively indirect inducers of apoptosis, since integrin-mediated adhesion promotes cell survival, whereas inhibiting normal integrin signaling triggers cell death. Now on page 459, Stupack et al. describe an active integrin-mediated death pathway, a finding that helps explain seemingly contradictory earlier results from inhibitor studies and targeted gene disruptions.

The authors studied adherent cells in an artificial three-dimensional extracellular matrix, and found that expression of unligated integrins or integrin ß subunit cytoplasmic domains in these cells induces apoptosis. The cells remained attached to the matrix while initiating cell death, distinguishing this integrin-mediated apoptotic pathway from anoikis, in which cells die after losing adherence. Instead, the unligated integrins recruit caspase 8 to the membrane and activate an apoptotic pathway that is independent of death receptors and distinct from stress-associated apoptosis.

Stupack et al. propose that integrins can act as biosensors, initiating apoptosis when a cell enters a microenvironment that lacks one or more ligands for its integrins. Integrin-mediated death may also explain why specific integrin antagonists cause apoptosis and inhibit angiogenesis, but humans or animals lacking the same integrins exhibit apparently normal angiogenesis. An antagonist that blocks integrin ligation would induce the active integrin-mediated death pathway, whereas disrupting expression of the integrin would only remove one of several possible triggers for apoptosis. {blacksquare}



Alan W. Dove

alanwdove{at}earthlink.net


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 211K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dove, A. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dove, A. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents